Enhanced Allicin Cytotoxicity on HEPG-2 Cells Using Glycyrrhetinic Acid Surface-Decorated Gelatin Nanoparticles

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2019 Aug 29

PMID 31460232

Citations 14

Authors

Muhammed Ossama

Rania M Hathout

Dalia A Attia

Nahed D Mortada

Affiliations

Soon will be listed here.

Abstract

The cytotoxic potential of allicin was evaluated on different cancer cell lines, particularly, hepatic (HepG-2), breast (MCF-7), lung (A-549), and prostatic (PC-3), where allicin scored an IC score of 19.26 μM on HepG-2. In order to increase the cell uptake, optimized allicin-loaded gelatin nanoparticles (GNPs) were prepared where the optimum formulation was surface-conjugated to glycyrrhetinic acid. GNPs were optimized using a D-optimal design. The optimum formulation had a particle size of 370.7 ± 6.78 nm and polydispersity index of 0.0363 ± 0.009 and 39.13 ± 2.38% of drug entrapment. The conjugation of the ligand, glycyrrhetinic acid with allicin-loaded GNPs, was confirmed utilizing H NMR. Drug release profiles in the presence/absence of collagenase were obtained. Finally, a cytotoxicity study on HepG-2 was performed for the unconjugated and conjugated allicin-loaded GNPs scoring IC of 10.95 and 5.046 μM, revealing two- and fourfold enhancements in allicin cytotoxicity, respectively. To our knowledge, the ligand-carrier pair, glycyrrhetinic acid-gelatin, was not explored before, and the developed system poses a successful liver cancer therapy.

Citing Articles

Incredible use of plant-derived bioactives as anticancer agents.

Kangra K, Kakkar S, Mittal V, Kumar V, Aggarwal N, Chopra H RSC Adv. 2025; 15(3):1721-1746.

PMID: 39835210 PMC: 11744461. DOI: 10.1039/d4ra05089d.

Allicin: a promising modulator of apoptosis and survival signaling in cancer.

Bhuker S, Kaur A, Rajauria K, Tuli H, Saini A, Saini R Med Oncol. 2024; 41(9):210.

PMID: 39060753 DOI: 10.1007/s12032-024-02459-6.

Enhancing Effector Jurkat Cell Activity and Increasing Cytotoxicity against A549 Cells Using Nivolumab as an Anti-PD-1 Agent Loaded on Gelatin Nanoparticles.

Ali D, Gad H, Hathout R Gels. 2024; 10(6).

PMID: 38920901 PMC: 11202840. DOI: 10.3390/gels10060352.

Allicin and Cancer Hallmarks.

Talib W, Baban M, Azzam A, Issa J, Ali A, AlSuwais A Molecules. 2024; 29(6).

PMID: 38542956 PMC: 10975206. DOI: 10.3390/molecules29061320.

Simplex Lattice Design and Machine Learning Methods for the Optimization of Novel Microemulsion Systems to Enhance p-Coumaric Acid Oral Bioavailability: In Vitro and In Vivo Studies.

Nasser N, Hathout R, Abd-Allah H, Sammour O AAPS PharmSciTech. 2024; 25(3):56.

PMID: 38448576 DOI: 10.1208/s12249-024-02766-1.

References

Coester C, Langer K, van Briesen H, Kreuter J . Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake. J Microencapsul. 2000; 17(2):187-93. DOI: 10.1080/026520400288427. View

Sahoo S, Labhasetwar V . Nanotech approaches to drug delivery and imaging. Drug Discov Today. 2003; 8(24):1112-20. DOI: 10.1016/s1359-6446(03)02903-9. View

Zwiorek K, Kloeckner J, Wagner E, Coester C . Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci. 2005; 7(4):22-8. View

Satomi Y, Nishino H, Shibata S . Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res. 2005; 25(6B):4043-7. View

Prager-Khoutorsky M, Goncharov I, Rabinkov A, Mirelman D, Geiger B, Bershadsky A . Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. Cell Motil Cytoskeleton. 2007; 64(5):321-37. DOI: 10.1002/cm.20185. View

He C, Hu Y, Yin L, Tang C, Yin C . Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010; 31(13):3657-66. DOI: 10.1016/j.biomaterials.2010.01.065. View

Chen H, Khemtong C, Yang X, Chang X, Gao J . Nanonization strategies for poorly water-soluble drugs. Drug Discov Today. 2010; 16(7-8):354-60. DOI: 10.1016/j.drudis.2010.02.009. View

Melino S, Sabelli R, Paci M . Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy. Amino Acids. 2010; 41(1):103-12. DOI: 10.1007/s00726-010-0522-6. View

Negishi M, Irie A, Nagata N, Ichikawa A . Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta. 1991; 1066(1):77-82. DOI: 10.1016/0005-2736(91)90253-5. View

10.

Kumar R, Nagarwal R, Dhanawat M, Pandit J . In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles. J Biomed Nanotechnol. 2011; 7(3):325-33. DOI: 10.1166/jbn.2011.1290. View

11.

Kelkel M, Cerella C, Mack F, Schneider T, Jacob C, Schumacher M . ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis. Carcinogenesis. 2012; 33(11):2162-71. DOI: 10.1093/carcin/bgs240. View

12.

ElHefnawi M, ElGamacy M, Fares M . Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors. BMC Bioinformatics. 2013; 13 Suppl 17:S5. PMC: 3521232. DOI: 10.1186/1471-2105-13-S17-S5. View

13.

Mishra N, Yadav N, Rai V, Sinha P, Yadav K, Jain S . Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int. 2013; 2013:382184. PMC: 3826320. DOI: 10.1155/2013/382184. View

14.

Gooding M, Adigbli D, Chan A, Melander R, MacRobert A, Selwood D . A bifurcated proteoglycan binding small molecule carrier for siRNA delivery. Chem Biol Drug Des. 2014; 84(1):24-35. PMC: 4286013. DOI: 10.1111/cbdd.12295. View

15.

Borlinghaus J, Albrecht F, Gruhlke M, Nwachukwu I, Slusarenko A . Allicin: chemistry and biological properties. Molecules. 2014; 19(8):12591-618. PMC: 6271412. DOI: 10.3390/molecules190812591. View

16.

Farid M, Hathout R, Fawzy M, Abou-Aisha K . Silencing of the scavenger receptor (Class B - Type 1) gene using siRNA-loaded chitosan nanaoparticles in a HepG2 cell model. Colloids Surf B Biointerfaces. 2014; 123:930-7. DOI: 10.1016/j.colsurfb.2014.10.045. View

17.

Hathout R, Omran M . Gelatin-based particulate systems in ocular drug delivery. Pharm Dev Technol. 2015; 21(3):379-86. DOI: 10.3109/10837450.2014.999786. View

18.

Qi W, Yu H, Guo H, Lou J, Wang Z, Liu P . Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy. Mol Pharm. 2015; 12(3):675-83. DOI: 10.1021/mp500394v. View

19.

Prabhu R, Patravale V, Joshi M . Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015; 10:1001-18. PMC: 4324541. DOI: 10.2147/IJN.S56932. View

20.

Metwally A, Hathout R . Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery. Mol Pharm. 2015; 12(8):2800-10. DOI: 10.1021/mp500740d. View